• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于胰岛素瘤的新型诊断模型。

A novel diagnostic model for insulinoma.

作者信息

Wang Feng, Yang Zhe, Chen XiuBing, Peng Yiling, Jiang HaiXing, Qin ShanYu

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.

出版信息

Discov Oncol. 2022 Aug 2;13(1):68. doi: 10.1007/s12672-022-00534-w.

DOI:10.1007/s12672-022-00534-w
PMID:35916979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346017/
Abstract

The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) - (1.851 × HbA1c) - (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) - (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was - 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ - 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia.

摘要

目的是描述一种简单可行的胰岛素瘤诊断模型。这项回顾性研究纳入了广西医科大学第一附属医院的37例胰岛素瘤患者和44例非胰岛素瘤所致低血糖患者。记录了一般人口统计学和临床特征、糖化血红蛋白(HbA1c)、胰岛素和C肽浓度,以及2小时口服葡萄糖耐量试验(OGTT)结果,并确定了预测胰岛素瘤的逻辑回归模型。体重指数(BMI)、HbA1c浓度、0小时C肽浓度以及0小时和1小时血浆葡萄糖浓度(各P<0.05)与胰岛素瘤独立相关。通过多变量逻辑回归分析建立回归预测模型:Logit p = 7.399 +(0.310×BMI)-(1.851×HbA1c)-(1.467×0小时血浆葡萄糖)+(1.963×0小时C肽)-(0.612×1小时血浆葡萄糖)。使用该指标绘制受试者工作特征(ROC)曲线,发现曲线下面积(AUC)为0.957。最佳截断值为-0.17,灵敏度为89.2%,特异性为86.4%。Logit P≥-0.17可作为预测低血糖患者胰岛素瘤的诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e1/9346017/0ec55ec721a2/12672_2022_534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e1/9346017/630acc17aeca/12672_2022_534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e1/9346017/0ec55ec721a2/12672_2022_534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e1/9346017/630acc17aeca/12672_2022_534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e1/9346017/0ec55ec721a2/12672_2022_534_Fig2_HTML.jpg

相似文献

1
A novel diagnostic model for insulinoma.一种用于胰岛素瘤的新型诊断模型。
Discov Oncol. 2022 Aug 2;13(1):68. doi: 10.1007/s12672-022-00534-w.
2
Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.利用口服葡萄糖耐量试验 2 小时期间胰岛素和 C 肽的分泌比值诊断胰岛素瘤。
Dig Dis Sci. 2021 May;66(5):1533-1539. doi: 10.1007/s10620-020-06379-z. Epub 2020 Jun 11.
3
A Systematic Review of the Accuracy of Insulin and C-peptide Secretion Ratios During the Oral Glucose Tolerance Test to Diagnose Insulinoma.口服葡萄糖耐量试验中胰岛素和 C 肽分泌比值诊断胰岛素瘤的准确性的系统评价。
J ASEAN Fed Endocr Soc. 2024;39(1):79-83. doi: 10.15605/jafes.039.01.16. Epub 2024 Feb 5.
4
Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test.在5小时口服葡萄糖耐量试验期间,利用胰岛素和C肽的血清浓度与葡萄糖的比值诊断胰岛素瘤。
Endocr J. 2017 Jan 30;64(1):49-57. doi: 10.1507/endocrj.EJ16-0292. Epub 2016 Oct 1.
5
[Diagnostic value of parameters of glucose metabolism as screening tests for insulinoma].
Zhonghua Yi Xue Za Zhi. 2010 Apr 27;90(16):1093-6.
6
Clinical implications of various criteria for the biochemical diagnosis of insulinoma.各种胰岛素瘤生化诊断标准的临床意义。
Endocrinol Metab (Seoul). 2014 Dec 29;29(4):498-504. doi: 10.3803/EnM.2014.29.4.498. Epub 2014 Jul 2.
7
Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma.胰岛素瘤患者的葡萄糖代谢指标及动态血糖监测系统(CGMS)的特点
Diabetol Metab Syndr. 2017 Mar 14;9:17. doi: 10.1186/s13098-017-0215-3. eCollection 2017.
8
Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.改良胰岛素-葡萄糖比值对胰岛素瘤生化诊断的准确性。
Ann Intern Med. 2012 Dec 4;157(11):767-75. doi: 10.7326/0003-4819-157-11-201212040-00004.
9
[Characteristics of 72 h glucose profiles detected by continuous glucose monitoring system in patients with insulinoma].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jul;45(4):623-7.
10
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.

引用本文的文献

1
Diagnostic Risk Prediction Models for Upper Gastrointestinal Cancers: A Systematic Review.上消化道癌症的诊断风险预测模型:一项系统评价
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1240-1251. doi: 10.1158/1055-9965.EPI-24-1714.
2
Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors.寻找神经内分泌肿瘤的新型生物标志物:神经内分泌肿瘤患者中嗜铬粒蛋白 A 与炎症细胞因子的对比分析。
Curr Oncol. 2024 Oct 12;31(10):6110-6132. doi: 10.3390/curroncol31100456.

本文引用的文献

1
Insulinomas: from diagnosis to treatment. A review of the literature.胰岛素瘤:从诊断到治疗。文献复习。
J BUON. 2020 May-Jun;25(3):1302-1314.
2
Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.利用口服葡萄糖耐量试验 2 小时期间胰岛素和 C 肽的分泌比值诊断胰岛素瘤。
Dig Dis Sci. 2021 May;66(5):1533-1539. doi: 10.1007/s10620-020-06379-z. Epub 2020 Jun 11.
3
[Insulinoma].
Rev Prat. 2019 Sep;69(7):e250.
4
Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening.空腹血浆葡萄糖和糖化血红蛋白水平乘积指数在胰岛素瘤筛查中的作用。
Endocr J. 2020 May 28;67(5):509-513. doi: 10.1507/endocrj.EJ19-0357. Epub 2020 Feb 4.
5
The functioning side of the pancreas: a review on insulinomas.胰腺的功能侧:胰岛素瘤综述。
J Endocrinol Invest. 2020 Feb;43(2):139-148. doi: 10.1007/s40618-019-01091-w. Epub 2019 Jul 31.
6
Exendin-4 analogs in insulinoma theranostics.艾塞那肽-4类似物在胰岛素瘤诊疗中的应用
J Labelled Comp Radiopharm. 2019 Aug;62(10):656-672. doi: 10.1002/jlcr.3750.
7
Keeping a Low Profile: Insulinoma.
Am J Med. 2019 Oct;132(10):1160-1162. doi: 10.1016/j.amjmed.2019.04.017. Epub 2019 May 3.
8
Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients.镓- DOTATATE PET/CT可作为胰岛素瘤患者的一种替代成像方法。
J Nucl Med Technol. 2017 Sep;45(3):198-200. doi: 10.2967/jnmt.117.192708. Epub 2017 Aug 10.
9
Efficacy of laparoscopic ultrasonography in laparoscopic resection of insulinoma.腹腔镜超声检查在胰岛素瘤腹腔镜切除术中的疗效
Endosc Ultrasound. 2017 May-Jun;6(3):149-155. doi: 10.4103/2303-9027.194703.
10
Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma.胰岛素瘤患者的葡萄糖代谢指标及动态血糖监测系统(CGMS)的特点
Diabetol Metab Syndr. 2017 Mar 14;9:17. doi: 10.1186/s13098-017-0215-3. eCollection 2017.